文献速递膀胱癌与上尿路尿路上皮癌

机器人腹腔内Hautmann原位新膀胱技术改进与围手术期及功能结局

Refinement Surgical Technique, and Perioperative and Functional Outcomes in Patients With Robotic Intracorporeal Hautmann Orthotopic Neobladder.
PubMed 文献 · Urology · 2020-01-30

单术者对40例膀胱癌患者行机器人辅助根治性膀胱切除加腹腔内Hautmann原位新膀胱,中位随访14个月。90天总体并发症率45%、高级别10%,日间满意控尿率6和12个月均90%,夜间分别为76.7%和80.0%,6个月平均容量328.7 cm3。

要点

  • 机器人腹腔内Hautmann新膀胱可行,90天高级别并发症率10%
  • 日间满意控尿率6和12个月均达90%
  • 6个月平均容量328.7 cm3,残余尿少、顺应性正常

核心结论

  • 机器人腹腔内Hautmann新膀胱构型是可行的手术技术,可获得低压、足够容量和满意的早期排尿模式。
  • 分步流程的改进可有效缩短手术时间,但长期功能和肿瘤学结局仍需更长随访和更多病例评估。

研究设计与样本

  • 评估基线人口学、病理资料、90天并发症以及6个月和12个月问卷与尿动力学功能结局。

主要发现

  • 中位随访14个月(范围4-20),中位手术时间320分钟(范围230-500),估计失血量300 mL(范围100-2000),无中转开放。
  • 90天总体并发症率45%,高级别并发症率仅10%。
  • 日间满意控尿率6个月(30例)和12个月(20例)均为90%,夜间满意控尿率6个月为76.7%、12个月为80.0%。
  • 1例患者行清洁间歇导尿。
  • 术后6个月队列残余尿量少、顺应性正常,平均容量328.7 cm3(范围170-500)。

临床怎么用

  • 该技术可作为膀胱癌根治后尿流改道的可选术式,早期排尿功能满意且高级别并发症率较低。
  • 分步流程改进有助于缩短手术时间,术后需关注夜间控尿和间歇导尿需求。

局限性

  • 样本量40例、中位随访仅14个月,长期功能和肿瘤学结局尚未评估。
  • 单术者、单中心经验,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To illustrate our refinement technique for robotic intracorporeal orthotopic Hautmann neobladder with adherence to open surgical principles and evaluate perioperative and functional outcomes. PATIENTS AND METHODS: Robot-assisted radical cystectomy with intracorporeal Hautmann orthotopic neobladder was performed by the same surgeon in 40 patients with bladder cancer from November 2017 to March 2019. Baseline demographics, pathologic data, 90-day complications, and functional outcomes at both 6 and 12 months were evaluated with questionnaire and urodynamic analysis. RESULTS: Median follow-up was 14 months (range 4-20). Median operative time was 320 (230-500) minutes, and the estimated blood loss was 300 (100-2000) mL. No conversion to the open technique was reported. The overall 90-day complication rate was 45%, and the high-grade complication rate was only 10%. The daytime satisfactory continence rate was 90% at both 6 months (30 patients) and 12 months (20 patients), while the night-time satisfactory continence rate was 76.7% and 80.0% at 6 months and 12 months, respectively. One patient underwent clean intermittent catheterization. The cohort had minimal postvoid residual volume, normal compliance, and a mean capacity of 328.7 cm3 (range 170-500) at 6 months postoperatively. CONCLUSION: Our preliminary data indicate that robotic intracorporeal Hautmann neobladder configuration is a feasible surgical technique and can achieve a low pressure and sufficient capacity for satisfactory early voiding patterns. Refinement of the stepwise process can effectively decrease the time of the operation. Long-term functional and oncological outcomes remain to be evaluated with longer follow-up and more cases.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Zhou X, Zheng J, He P, et al. Refinement Surgical Technique, and Perioperative and Functional Outcomes in Patients With Robotic Intracorporeal Hautmann Orthotopic Neobladder. Urology. 2020. PMID: 32006548. doi:10.1016/j.urology.2020.01.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。